Microfluidic applications in the pharmaceutical, life sciences, in vitro diagnostic and medical device markets report How life science and in vitro diagnostics applications are driving an impressive 27% growth for the microfluidic device market. The microfluidic device market is expected to reach $5.7B by 2018! The microfluidic device market will grow swiftly, from $1.4B in 2013 to $5.7B by 2018. This impressive 27% growth will be fueled mainly by Pharmaceutical research and Point-of-Care applications. Facing new challenges, the healthcare industry is currently moving toward personalized medicine. In this context, the line between traditional markets (pharmaceutical and in vitro diagnostic markets) has blurred. More than ever, rapid, accurate tests are needed to increase pharmaceutical research yield and better monitor/cure patients. By offering innovative solutions, microfluidic technologies have successfully managed to fill the gap. This new Yole Développement report provides a complete analysis of microfluidic device markets and technologies. Based on an accurate investigation of the last three years’ events, this report consolidates market data from 2010-2012 and provides forecasts for 2013-2018. Microfluidic devices can be produced either by pure microfluidics fabs or in-house by fully integrated players. After revealing the top 15 pure microfluidic fab players, the report looks at the “hidden” market linked to in-house production. These microfluidic devices can either be used directly for some applications (analytical devices, flow chemistry, etc.) or must be completed by reagents/biological content. The distinction between the microfluidic device market (first-level package device) and the microfluidic technologybased test market has also been calculated. Discover the microfluidic market’s complex organization, broken down in nine segments Today, microfluidic devices are widely accepted in several applications. Nevertheless, the advantages and motivations for adopting microfluidic technologies are highly-dependent on the targeted application. For example, the added value of microfluidic devices in Point-of-Care applications depends on the associated small volume of necessary reagents, low-cost disposables and high sensibility. Contrarily, the advantages for pharmaceutical research applications are to allow process automation and multiplexed assays. More information on the report at http://www.i-micronews.com/reports/Microfluidic-pharmaceutical-life-sciences-vitro-diagnostic/4/376/

1. Microfluidic Applications 2013
How Life Science and In-Vitro-Diagnostics applications are driving an impressive
27% growth for the microfluidic devices market?

2. © 2013 • 2
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Table of Content (1/2)
1- Executive Summary (p.4)
2- Introduction (p.34)
• Introduction
• Methodology
• Objectives of the report
• Companies Cited in This Report
• What’s new since 2011?
3- What happened since 2011 (p.40)
• Microfluidic Device Market in 2011
• EMMA2011 forecast versus real market data
• Microfluidic Device Market in 2012
• Market data versus EMMA 2011 forecasts
• Major changes for Microfluidic Devices Market
• New Collaborations
• Acquisitions
4- Microfluidic markets 2011-2018 (p.51)
• Microfluidic Markets Introduction
• Microfluidic Player World in 2012
• Microfluidic Devices Market
• Market Data: Our vision of the market
• Pure Fab Players: TOP 15
• Microfluidic Chips Market
• Microfluidic Test Market

3. © 2013 • 3
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Table of Content (2/2)
5- Microfluidic Applications (p.89)
6- Materials Mix Analysis (p.97)
• Material Mix for Point Of Care Testing
• Material Mix for Pharmaceutical and Life Science
• Silicon for Pharmaceutical Research chips
7- Microfluidic Product Description (p.105)
• Information Provided for Each Class of Products
• Flow control components and modules
• Microfluidic Dispensing Devices for Drug Delivery
• Microfluidic Devices for Accurate Dispensing
• Microfluidics for Analytical Devices
• Cartridges for Clinical and Veterinary Diagnostics
• Microfluidic Devices for Point of Care
• Microfluidics for Industrial and Environmental Testing
• Microfluidics for Pharmaceutical and Life Science Research
• Microfluidic Devices for Micro Reactions
8- Emerging Applications (p.221)
9- Microfluidic technologies (p.238)
10- Microfluidics Value Chain (p.263)
11- Microfluidics Supply Chain (p.271)
12- Summary and Conclusions

4. © 2013 • 4
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Companies Cited in This Report
AB SCIEX, Abaxis, Abbott, Advion Biosciences, AES Laboratoire , Agilent Technologies,
Bartels mikrotechnik, BD, Bertin Technologies, Biodiot, BioFluidix, bioMérieux, Biosite,
Boehringer Ingelheim , Bürkert, Caliper Life Sciences, Cellectricon, Cepheid, Cetoni ,
Cytoo, Dalsa, Danaher, Debiotech, Dolomite, Eksigent Technologies, Epocal, Fluidigm,
Fluigent, GE Novasensor, GenePOC Genewave, GeSim, Great Basin, Hamilton, Ikerlan,
Illumina, IMM, Invitrogen, Johnson & Johnson, Konica Minolta Opto, LabCyte, Life
Technologies, Merlin diagnostic, MicroCHIPS, Micronit, MicroParts, Nanostream, Ocusense,
Pall Genesystem, PerkinElmer, Philips, PositiveID Corporation, Qiagen, Raindance
Technologies, Roche Applied Science, Samsung, Scienion, Sensirion, Seyonic, Shimatzu,
Biotech , Shrink Nanotechnologies, Siemens Medical Solutions, Sony DADC, Sophion,
SpinChip Diagnostics, Stmicroelectronics, Texas Instrument, Tokyo Electron, Vantix Ltd, and
many others…

5. © 2013 • 5
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Life sciences
Markets Considered in This Report
Pharmaceutical
R&D spending ~17% of
annual turnover
source PhRma
Medical DevicesIn Vitro Diagnostics
Environment
control
• water
monitoring,
• homeland
security,…
Agrofood
control
. process
control,
traceability,
…
Medical equipment
development and
commercialization
$295B 2012
Microfluidics
contribution: $174M
Source Yole estimation
R&D spending around
8% of sales
source Eucomed
Biological test
development and
commercialization
$57B 2012
Microfluidics
contribution: $787M
Source Yole estimation
Drug discovery and
commercialization
$870B 2012
Source IMS Health, VFA
Microfluidics
contribution: $412M
Source Yole estimation
Medical Home Care
Prescribed Medical
devices and services
for home care
~$54B 2012
Microfluidics
contribution: $0M
Source Yole estimation
Wide range of products.
Excludes consumer health
and sport products

6. © 2013 • 6
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Microfluidic Devices Market
0
1
2
3
4
5
6
2012 2013 2014 2015 2016 2017 2018
MicrofluidicDevicesMarketin$B
$B
Microfluidic Devices Market in $B

7. © 2013 • 7
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Microfluidic Functions & Applications
= Microfluidics chips
Legend:
Medical
applications
In Vitro Diagnostic applications
Research & Production
applications
Drug Delivery
Analytical
Device
Clinical & Veterinary
Diagnostics
Point Of Care
Industrial &
Environment
Testing
Pharmaceutical
research
Microreaction
Dispensing
Micro analysis devices
Chemical & biological
Synthesis
Applications
Functions
Flow control components and modules
Inhalers
Microneedles
Devices for dispensing,
spotting
Devices for
dispensing,
spotting
Devices for Micro
Reaction used in:
- Research units
- Pilot production
units
Chips for
Analyses
Cartridges for
clinical and
veterinary
diagnostics
Chips for
POC
Intensive
care, doctor
office, near
patient,…
Chips
Identification
of pathogens
(Agro Food,
Water analysis)
Chips for
Genomics
Proteomics
Cell based
assays

8. © 2013 • 8
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
• Microfluidics has entered the Life Sciences market as a key technology to provide
solution adapted to the market requirements.
• This new Yole report provides a complete analysis of microfluidic devices markets
and technologies. Based on an exclusive segmentation of the market, both market
trends, main players are presented for each product category.
Objectives of the report

9. © 2013 • 9
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Microfluidics Materials
Main Materials used
in Microfluidics
Silicon
Glass
D 263
B 270
Borosilicate
Borofloat
Fused silica
Pyrex
Polymer
SU-8
PMMA
COC
PDMS
PTFE
PI
COP
PEEK
PET

10. © 2013 • 10
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Materials Mix Analysis
Recent changes in the Materials Mix
are opening new opportunities for Silicon Players!

11. © 2013 • 11
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Market Data: Our vision of the market
Microfluidics
Chip
Market
Tests based on
Microfluidic
Market
Pure µfluidics Fabs
Fully
Integrated
players
From substrate to
test
OEM, Instrument
manufacturers
Diagnostic Companies
Reagents
Biological Content
Margin
Diagnostic
companies
with design
capabilities
Non Specialized
Fabs

12. © 2013 • 12
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Emerging Microfluidic Applications
Emerging
Applications
Paper based microfluidicsNew auto-focus solution
Touchscreen components
Micro Total Analysis System
for mobile Care

13. © 2013 • 13
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
More information, please contact
Benjamin Roussel, PhD
Technology & Market Analyst
Microfluidics & Medical Technologies
Email : benjamin.roussel@yole.fr – Skype : broussel_yole
Phone : +33 472 83 01 04
Le Quartz, 75 Cours Emile Zola – 69100 Villeurbanne
Lyon – FRANCE
www.yole.fr – www.i-micronews.com

14. © 2013 • 14
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
MedTech reports from YOLE
LatestMedTech Reports Upcoming
TIME

15. © 2013 • 15
EMMA 2013 June 2013 Copyrights © Yole Développement SA. All rights reserved.
Yole activities in MedTech
Media business
News feed / Magazines /
Webcasts
Reports
Market
Research
Consulting services
Market research,
Technology & Strategy
www.yole.fr